TPB — Turning Point Brands, Inc.

Is TPB overbought or oversold? Here is the current MarketMoodz read.

Consumer Defensive · Tobacco

Strong Oversold As of November 17, 2026

Turning Point Brands, Inc. (TPB) currently reads Strong Oversold on the MarketMoodz overbought/oversold meter, as of November 17, 2026. The Consumer Defensive name (Tobacco) last closed at $49.51. The rating moved from Oversold to Strong Oversold on November 12, 2026.

See all oversold Consumer Defensive stocks →

AI analysis

Turning Point Brands, Inc. (TPB) presents a mixed short-term outlook: its niche nicotine and alternative tobacco product portfolio and established retail distribution provide revenue stability, while the current market rotation into defensive consumer names supports measured demand. Absence of fresh filings or strong social sentiment leaves the stock in a consolidation phase with limited near-term catalysts. Key upside drivers include successful product innovation, stable retail placements and controlled operating costs; downside scenarios center on regulatory action, competitive share loss, and input/supply-chain pressures. Given these dynamics, performance over the next month will likely track sector flows and any regulatory headlines rather than macro surprises.

Key factors

  • Turning Point Brands, Inc. (TPB) occupies a niche in nicotine and alternative tobacco products with established retail distribution and brand placements that support recurring revenue.
  • Current market backdrop shows rotation into defensive consumer staples, which can provide relative stability and selective buying interest for TPB versus higher-beta names.
  • Product portfolio and diversified SKUs across combustible and non-combustible segments provide cross-channel sales resilience and potential to capture shifting consumer preferences within nicotine categories.
  • Operational execution and margin control historically matter more than top-line surprises for near-term performance given modest volatility and limited macro-driven catalysts in the immediate window.
  • Limited recent public filings and sparse social/research coverage reduce near-term informational catalysts but also limit market expectations dispersion.

Risks

  • Regulatory and legislative risk targeting flavored vaping and nicotine products, which could compress addressable market or require costly product changes.
  • Demand erosion or faster-than-expected consumer migration away from core product categories, driven by health trends or competitive innovation.
  • Concentration risk from reliance on a limited set of retail partners or product lines; loss of placement or major account shifts could materially impact sales.
  • Input cost inflation, supply-chain disruptions, or increased freight/manufacturing expenses that pressure margins.
  • Competitive pressure from larger tobacco companies and private-label alternatives that may undercut pricing or accelerate shelf-share loss.
  • Small-cap liquidity and episodic volatility can exaggerate price moves absent strong company-specific news flow.

See today's live rating, score and targets

Members see the live hourly rating for TPB — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.